Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1053

1.

Angiotensin-converting enzyme insertion/deletion polymorphism and susceptibility to Henoch-Schönlein purpura: a meta-analysis.

Zhang X, Wu L, Chai M, Huang X, Zhu J, Li S, Zhang J, Zhang H.

J Renin Angiotensin Aldosterone Syst. 2019 Jan-Mar;20(1):1470320319836302. doi: 10.1177/1470320319836302.

2.

Syndrome of inappropriate secretion of antidiuretic hormone associated with angiotensin-converting enzyme inhibitor therapy in the perioperative period.

Nakayama T, Fujisaki H, Hirai S, Kawauchi R, Ogawa K, Mitsui A, Hirano K, Isozumi K, Takahashi T, Komatsumoto S.

J Renin Angiotensin Aldosterone Syst. 2019 Jan-Mar;20(1):1470320319834409. doi: 10.1177/1470320319834409.

3.

The selective mineralocorticoid receptor modulator AZD9977 reveals differences in mineralocorticoid effects of aldosterone and fludrocortisone.

Bamberg K, William-Olsson L, Johansson U, Jansson-Löfmark R, Hartleib-Geschwindner J.

J Renin Angiotensin Aldosterone Syst. 2019 Jan-Mar;20(1):1470320319827449. doi: 10.1177/1470320319827449.

4.

Association between angiotensinogen T174M polymorphism and the risk of diabetic nephropathy: A meta-analysis.

Liu N, Wang Y.

J Renin Angiotensin Aldosterone Syst. 2019 Jan-Mar;20(1):1470320318823927. doi: 10.1177/1470320318823927.

5.

Association of mononucleotide polymorphisms of angiotensinogen gene at promoter region with antihypertensive response to angiotensin receptor blockers in hypertensive Chinese.

Gong HT, Mu LY, Zhang T, Xu XY, Du FH.

J Renin Angiotensin Aldosterone Syst. 2019 Jan-Mar;20(1):1470320319827205. doi: 10.1177/1470320319827205.

6.

Association of angiotensin ІІ type 1 receptor gene A1166C polymorphism with cancer risk: An updated meta-analysis.

Hu X, Chen J.

J Renin Angiotensin Aldosterone Syst. 2019 Jan-Mar;20(1):1470320319827207. doi: 10.1177/1470320319827207.

7.

The association between apelin polymorphisms and hypertension in China: A meta-analysis.

Wang T, Liu C, Jia L, Ding J.

J Renin Angiotensin Aldosterone Syst. 2019 Jan-Mar;20(1):1470320319827204. doi: 10.1177/1470320319827204.

8.

The relationship between plasma renin activity and serum lipid profiles in patients with primary arterial hypertension.

Pizoń T, Rajzer M, Wojciechowska W, Wach-Pizoń M, Drożdż T, Wróbel K, Gruszka K, Rojek M, Kameczura T, Jurczyszyn A, Kąkol J, Czarnecka D.

J Renin Angiotensin Aldosterone Syst. 2018 Oct-Dec;19(4):1470320318810022. doi: 10.1177/1470320318810022.

9.

Salt and cardiovascular disease in PURE: A large sample size cannot make up for erroneous estimations.

Tan M, He FJ, MacGregor GA.

J Renin Angiotensin Aldosterone Syst. 2018 Oct-Dec;19(4):1470320318810015. doi: 10.1177/1470320318810015.

10.

Prenatal hypocalvaria after prolonged intrauterine exposure to angiotensin II receptor antagonists.

Lallemant M, Prévost S, Nobili F, Riethmuller D, Ramanah R, Seronde MF, Mottet N.

J Renin Angiotensin Aldosterone Syst. 2018 Oct-Dec;19(4):1470320318810940. doi: 10.1177/1470320318810940.

11.

His-Leu, an angiotensin I-derived peptide, does not affect haemodynamics in rats.

Drapała A, Bielińska K, Konopelski P, Pączek L, Ufnal M.

J Renin Angiotensin Aldosterone Syst. 2018 Oct-Dec;19(4):1470320318808879. doi: 10.1177/1470320318808879.

12.
13.

Long-term clinical spectrum and circulating RAS evaluation of anephric patients undergoing hemodialysis: A report of four cases and literature review.

Liu L, Zhang Y, Fu F, Zhuo L, Wang Y, Li W.

J Renin Angiotensin Aldosterone Syst. 2018 Jul-Sep;19(3):1470320318799904. doi: 10.1177/1470320318799904. Review.

14.

Hyperglycemia activates the renin-angiotensin system and induces epithelial-mesenchymal transition in streptozotocin-induced diabetic kidneys.

Chen CM, Juan SH, Chou HC.

J Renin Angiotensin Aldosterone Syst. 2018 Jul-Sep;19(3):1470320318803009. doi: 10.1177/1470320318803009.

15.

Angiotensin IV suppresses inflammation in the brains of rats with chronic cerebral hypoperfusion.

Wang QG, Xue X, Yang Y, Gong PY, Jiang T, Zhang YD.

J Renin Angiotensin Aldosterone Syst. 2018 Jul-Sep;19(3):1470320318799587. doi: 10.1177/1470320318799587.

16.

A randomized trial of the efficacy and safety of azilsartan medoxomil combined with chlorthalidone.

Weber MA, Sever P, Juhasz A, Roberts A, Cao C.

J Renin Angiotensin Aldosterone Syst. 2018 Jul-Sep;19(3):1470320318795000. doi: 10.1177/1470320318795000.

17.

Orthotopic renal autotransplantation for young-onset and medical treatment-requiring complex renovascular hypertension.

Li FD, Ji ZG, Liu CW, Shao J, Xie Y, Zheng YH.

J Renin Angiotensin Aldosterone Syst. 2018 Jul-Sep;19(3):1470320318789861. doi: 10.1177/1470320318789861.

18.

Elevated plasma aldosterone levels are associated with a reduction in retinal ganglion cell survival.

Takasago Y, Hirooka K, Nakano Y, Kobayashi M, Ono A.

J Renin Angiotensin Aldosterone Syst. 2018 Jul-Sep;19(3):1470320318795001. doi: 10.1177/1470320318795001.

19.

Retinal angiotensin II and angiotensin-(1-7) response to hyperglycemia and an intervention with captopril.

Senanayake PD, Bonilha VL, W Peterson J, Yamada Y, Karnik SS, Daneshgari F, Brosnihan KB, Hollyfield JG.

J Renin Angiotensin Aldosterone Syst. 2018 Jul-Sep;19(3):1470320318789323. doi: 10.1177/1470320318789323.

20.

Age-related changes in vascular responses to angiotensin-(1-7) in female mice.

Costa-Fraga FP, Goncalves GK, Souza-Neto FP, Reis AM, Capettini LA, Santos RA, Fraga-Silva RA, Stergiopulos N, da Silva RF.

J Renin Angiotensin Aldosterone Syst. 2018 Jul-Sep;19(3):1470320318789332. doi: 10.1177/1470320318789332.

Supplemental Content

Loading ...
Support Center